Prolonged survival of a patient with lung cancer after treatment with S-1, a new oral fluoropyrimidine anticancer drug

Author： Urata Yoshiko   Negoro Shunichi   Satouchi Miyako   Kurata Takayasu   Yoshimura Sho   Shimada Temiko   Takada Yoshiki  

Publisher： Humana Press, Inc

ISSN： 1357-0560

Source： Medical Oncology, Vol.24, Iss.1, 2007-01, pp. : 103-107

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1M tegafur-0.4M gimestat-1M otastat potassium) in advanced gastric cancer patients

By Sakata Y.   Ohtsu A.   Horikoshi N.   Sugimachi K.   Mitachi Y.   Taguchi T.  

European Journal of Cancer, Vol. 34, Iss. 11, 1998-10 ,pp. : 1715-1720

Elsevier

Access to resources Recommend Favorite

Combination therapy of human pancreatic cancer implanted in nude mice by oral fluoropyrimidine anticancer agent (S-1) with interferon-alpha

By Miyake Kotaro   Tsuchida Kunihiro   Sugino Hiromu   Imura Satoru   Morine Yuji   Fujii Masahiko   Shimada Mitsuo  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 1, 2007-01 ,pp. : 113-126

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of S-1, a novel oral fluoropyrimidine, and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancer

By Oki Yasunari   Hirose Takashi   Yamaoka Toshimitsu   Kusumoto Sojiro   Shirai Takao   Sugiyama Tomohide   Okuda Kentaro   Nakashima Masanao   Murata Yasunori   Ohmori Tohru   Adachi Mitsuru  

Cancer Chemotherapy and Pharmacology, Vol. 67, Iss. 4, 2011-04 ,pp. : 791-797

Springer Publishing Company

Access to resources Recommend Favorite

Treatment with an oral fluoropyrimidine, S-1, plus cisplatin in patients who failed postoperative gemcitabine treatment for pancreatic cancer: a pilot study

By Togawa Akira   Yoshitomi Hideyuki   Ito Hiroshi   Kimura Fumio   Shimizu Hiroaki   Ohtsuka Masayuki   Yoshidome Hiroyuki   Kato Atsushi   Sawada Shigeaki   Miyazaki Masaru  

International Journal of Clinical Oncology, Vol. 12, Iss. 4, 2007-08 ,pp. : 268-273

Springer Publishing Company

Access to resources Recommend Favorite

A feasibility trial of postoperative adjuvant chemotherapy with S-1, an oral fluoropyrimidine, for elderly patients with non-small cell lung cancer: a report of the Lung Oncology Group in Kyushu (LOGIK) protocol 0901

By Maruyama Riichiroh   Ebi Noriyuki   Kishimoto Junji   Kato Masato   Yano Tokujiro   Nagamatsu Yoshinori   Tsukamoto Shuichi   Akamine Shinji   Saeki Sho   Ichinose Yukito  

International Journal of Clinical Oncology, Vol. 19, Iss. 1, 2014-02 ,pp. : 57-62

Springer Publishing Company

Access to resources Recommend Favorite